2019 Press Releases
November 19, 2019 Novel Alkylsilicates for Cross-Coupling
The commercial line of novel alkylsilicates are key building blocks for the cross-coupling reactions of sp3-sp2 and sp3-sp3 carbon centers that were developed by Professor Gary A. Molander at the University of Pennsylvania in 2016. Download the Technical Brochure
November 12, 2019 Gelest BIOSAFE in Certainty SmartBoost
Strategic Partners Inc. (SPI), the industry leader in medical uniforms, has selected BIOSAFE® antimicrobial fabric technology for use in their Certainty® SmartBoost™ laundry additive product.
November 1, 2019 Daria Carlin Long Promoted to VP and GM
Daria Carlin Long has been promoted to Vice President and General Manager of Gelest’s Personal Care Group. She brings more than 25 years’ experience in Specialty Chemicals, with a primary focus on commercial operations, marketing and business management in the personal care industry.
September 5, 2019 Dr. Barry Arkles Receives 2020 Kipping Award
Gelest, Inc. announced today that its Founder, President and Chief Technology Officer Dr. Barry Arkles is the recipient of the American Chemical Society 2020 Frederic Stanley Kipping Award in Silicon Chemistry. The award recognizing distinguished contributions to the field of silicon chemistry during the 10 years preceding the nomination.
August 20, 2019 Gelest Joins AMR Challenge
Gelest, Inc. joined The Antimicrobial Resistance (AMR) Challenge launched by the U.S. Government and CDC in September 2018. The AMR Challenge is an effort to accelerate the fight against antimicrobial resistance through committed action across governments and industries. Gelest manufactures BIOSAFE® Antimicrobials that inhibit microorganism growth by physically puncturing the cell microbe membrane, killing the microbes on contact by electrocuting them.
July 1, 2019 Gelest Acquires Bimax
Gelest announced its acquisition of Bimax of Pennsylvania, USA. Bimax is a leading manufacturer and marketer of high purity methacrylate and specialty monomers. These products complement Gelest’s reactive siloxane materials for the manufacture of contact lenses, intraocular lenses, dental composites, wound dressings, drug delivery, biomaterials, and other medical device products.
June 25, 2019 Silicon Precursors for Silicon Nitride
Introducing new silicon source precursors for silicon nitride (SiN) ultrathin film deposition in semiconductor applications. Gelest supports these new precursors with film deposition and process data from its newly established thin film applications lab.
June 6, 2019 SiBrid TM-031 D5 Alternative
Gelest Inc. has launched SiBrid® TM-031 personal care specialty silicone fluid with volatility and solubility characteristics similar to the cyclomethicone D5. Gelest showcased SiBrid® TM-031 (INCI: Propyl Trisiloxane) at the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day in New York.
April 9, 2019 Jim Whitlock Appointed COO
Gelest Inc., a leading innovator in materials science and technology and a New Mountain Capital portfolio company, has appointed Jim Whitlock to the newly created position of Chief Operations Officer (COO), effective immediately, to deepen its senior leadership team in conjunction with the company’s continuing growth.
March 4, 2019 John Sobchak Appointed CFO
Gelest Inc., a leading innovator in materials science and technology and a New Mountain Capital portfolio company, has appointed John Sobchak to the newly created position of Chief Financial Officer (CFO), effective immediately, to deepen its senior leadership team in conjunction with the company’s continuing growth.